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This study investigates the role of Smad3 signalling for the T-helper2 (Th2) cytokine homeostasis in normal lungs 
and in a mouse model of asthma. 
We used mice deficient for Smad3, a central part of the major signal transduction pathway for TGF-β and other 
related cytokines, and a mouse model for allergic asthma with ovalbumin (OVA) as the antigen. 
Compared to wild type mice, naive (unmanipulated) Smad3-/- mice exhibited significantly increased levels of 
proinflammatory cytokines and IL-4 as well as the Th2 associated transcription factor GATA-3 in the lung tissue 
and bronchoalveolar lavage (BAL). In the asthma model, mucin secretion and airway hyperresponsiveness 
(AHR) after allergen exposure was significantly increased in the Smad3-/- mice as compared to wild type (WT) 
mice. IL-4 levels in Smad3-/- were similar to those encountered in WT mice but IL-13 levels were decreased in the 
airways of OVA sensitized Smad3-/- mice compared to corresponding WT mice.  
The results indicate that a lack of Smad3 dependent signalling in the normal state will lead to an increase in the 
GATA-3 levels and as a result of this the levels of IL-4 increase. However, the lack of Smad3 also seems to inhibit 
expression of some cytokines, especially IL-13. Our results also indicate that in the inflammatory state TGF-β or 
related cytokines functions to counterbalance the effects of IL-4 rather than to critically regulate its expression. 
Key words: Smad3, TGF-β, Asthma. 
1.  INTRODUCTION 
Transforming growth factor -beta (TGF-β) is a 
central regulator of immunological activity. TGF-β 
regulates a variety of cellular responses, such as 
proliferation, differentiation, migration and apoptosis. 
TGF-β can either stimulate or inhibit immune cell 
function and opposite effects may be elicited at 
different concentrations [1]. Total disruption of the 
TGF-β1  gene has been reported to cause gross 
developmental abnormalities. These transgenic mice 
succumb about 20 days after birth to a wasting 
syndrome with a multifocal inflammatory response 
and tissue necrosis [2]. 
All three mammalian isoforms of TGF-β are 
present in the airways and at least TGF-β1 and TGF-β2 
have been shown to be increased in asthmatic airways 
and cells, with evidence of increased TGF-β signalling 
[3-5]. The increased expression of TGF-β in asthmatic 
airways and an increased number of infiltrated 
eosinophils have been shown to correlate with each 
other [6]. TGF-β1 polymorphism has been shown to be 
associated with asthma [7]. TGF-β1 has been shown to 
reverse airway inflammation and airway 
hyperresponsiveness (AHR) in experimental asthma 
models [8, 9]. TGF-β has also been detected in the BAL 
fluid of a murine model of asthma [10]. In the work by 
Scherf et al, where decreased expression of TGF-β1 was 
induced in an asthma model, an exaggerated asthmatic 
phenotype was seen [11]. A number of different 
immune cells and a complex array of cytokines are 
involved in the development of asthmatic 
inflammation. T-helper 2 (Th2) cells are known to be 
important in generating an inflammation that 
characterizes asthma and allergic disease. However, 
the regulation of inflammatory cascade and immune 
system signals involved in the generation of the Th2 
cell responses and, on the other hand, downregulating 
the inflammatory responses, is less well understood. In 
addition to TGF-β1, another member of the TGF 
superfamily, activin A has been suggested to be 
involved in the pathogenesis of asthma [12, 13].  
In order to initiate signalling, TGF-β binds to Int. J. Biol. Sci. 2007, 3 
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TGF-β receptor types I and II. TGF-β signals are 
delivered from the cytoplasm to the nucleus via TGF-β 
signal transducers called Smads. Smad3 is a central 
signal transducer in TGF-β -signalling [14]. Smads are 
intracellular proteins, transcription factors 42-65 kDa 
in mass [15, 16]. There are three families of Smads: 
receptor-activated Smads (Smads 1, 2, 3, 5 and 8), 
common-partner Smads (Smad 4) and the inhibitory 
Smads (Smads 6 and 7). Activin A binds to its own 
specific receptor, distinct from the TGF-β1 receptor, 
but both receptors share the same intracellular Smad 
signalling pathway [17]. After activation of type II and 
type I -receptors, the receptor-activated -Smads 
become phosphorylated and form heteromeric 
complexes with common partner -Smads, that 
translocate into the nucleus. In the nucleus, these 
complexes control the expression of target genes in a 
cell type specific manner. In a study using transgenic 
mice expressing Smad7, Nakao et al. demonstrated that 
blockade of TGF-β/Smad -signalling in T cells 
enhanced antigen-induced airway inflammation and 
airway reactivity [18].  
In this study we used Smad3 deficient transgenic 
mice to explore the role of Smad3 -signalling for 
cytokine homeostasis in the airways of naive Smad3-/- 
mice. In addition, we examined the role of Smad3 
-signalling in the regulation of bronchial 
hyperreactivity and inflammation in a murine model 
of asthma. 
2.  MATERIALS AND METHODS 
Mice 
Smad3 knock-out mice of the C57BL/6 strain 
were kindly provided by Dr. Chuxia Deng et al and 
were bred in our facilities. Mice heterozygous for the 
targeted disruption were intercrossed to produce 
homozygous offspring. The resulting progeny were 
screened by PCR to identify Smad3-/- and WT 
littermates [19]. Animals were used between seven to 
eleven weeks of age and were age and sex matched 
within each experiment. The mice were housed in 
pathogen free facilities. All animal protocols were 
approved by Health Services of State Provincial Office 
of Southern Finland. 
Induction of Allergic Airway Disease 
In this work we used a model for human asthma 
described by Hamelmann et al [20]. Mice were 
sensitized intraperitoneally on day 0 and 10 with 
ovalbumin in alum or PBS emulsified in alum. On days 
20-22, the mice were challenged with aerosolized 1% 
OVA, 20 minutes per day. Airway responsiveness was 
measured 24 hours after the last airway challenge and 
specimens were collected. Eight mice per group were 
challenged in three separate experiments.  
AHR 
Airway responsiveness was measured in mice 24 
h after the final OVA challenge by recording 
respiratory pressure curves by whole body 
plethysmography (Buxco Technologies, Troy, NY, 
USA) in response to nebulized methacholine (MCh) in 
PBS (Sigma-Aldrich; UK) at increasing concentrations 
of 3-100 mg/ml. After each nebulization, recordings 
were taken for five minutes and the results expressed 
as the increase in enhanced pause (PenH ) compared to 
baseline (nebulized PBS). Animals were sacrificed by 
CO2 asphyxiation and lung, serum and 
bronchoalveolar lavage (BAL) samples were collected 
for further analysis. 
Bronchoalveolar lavage and lung histology 
The chest cavity was opened and the lungs were 
lavaged with PBS via the trachea. The BAL sample was 
cytocentrifuged (Cytospin, Shandon Ltd, Pittsburgh, 
PA). The remaining cells were fixed in ethanol (50%). 
The total amount of cells was determined by counting 
the cells in a Burker chamber. After cytocentrifuging, 
the bronchoalveolar lavage cells were stained with 
May-Grünwald-Giemsa (MGG) stain and the 
percentage distribution of different types of cells were 
determined. One part of the left lung was removed for 
RNA isolation. The right lung was fixed in 10% 
formalin, embedded in paraffin wax, routinely 
processed, sectioned 5 μm thick, and stained with H&E 
and Periodic Acid Schiff (PAS) stains. For the mucin 
production the results are expressed as the length of 
basal membrane covered with PAS stained cells / 100 
μm stretch of basal membrane from the 3 bronchi in 
each slide showing the most PAS positivity. 
Immunoglobulins 
OVA-specific IgE and IgG2a  serum levels were 
measured by ELISA [21]. Bound IgG2a and IgE were 
detected with biotin-conjugated rat anti-mouse IgG2a 
and IgE mAb (BD, Pharmingen, San Jose, CA). 
Streptavidin-HRP (BD, Pharmingen, San Jose, CA) 
1/4000 in 1% BSA and peroxidase substrate 
(Kirkegaard & Perry Laboratories, Gaithersburg, MD) 
were used and absorbance measured at 405 nm with 
an ELISA reader (Multiskan MS, Labsystems, Vantaa, 
Finland). 
RT-PCR 
One part of the left lung was removed for RNA 
isolation. Total RNA from lungs was extracted and 
transcribed into cDNA. Real-time quantitative PCR 
was performed with an AbiPrism 7700 Sequence 
Detector System (Applied Biosystems, Foster City, CA, 
USA). PCR primers and probes were IL-13, IL-10, IL-4, 
IFN-γ, IL-1β, GATA-3, TGF-β1 and CCL3/MIP-1α 
(Applied Biosystems) and endogeneous 18S rRNA was 
used as the housekeeping gene and the target gene 
expression was expressed as relative units (RU) [22]. 
Measurement of cytokines by Luminex
TM 
IL-4, IL-5 and IL-13, cytokines of BAL-samples 
were measured on a LuminexTM system (Bio-Plex 200) 
using the Bio-Rad mouse cytokine kit (Bio-Plex 
cytokine assay) following the manufacturer's 
instructions. Data were collected with a minimum of 
100 beads per analyte using Bio-Plex Manager 
Software (Bio-Rad Laboratories, Inc, Hercules, CA).  Int. J. Biol. Sci. 2007, 3 
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Data Analysis 
Data were analyzed with the GraphPadPrism 
software (GraphPad Software, Inc., San Diego, CA). 
Data are expressed as mean +/- SEM. Statistical 
significance was accepted when P<0.05 using the 
Mann Whitney U Test. 
3.  RESULTS 
Effects of the Smad3 deletion on normal mouse 
airways 
In general there were only minor morphological 
changes in the lungs of Smad3-/- lungs as compared to 
WT lungs. H&E stained lung sections revealed a 
marginal increase in peribronchial lymphocytes (also a 
few eosinophils and neutrophils were observed) in 
naive Smad3-/- mice. In addition in some mice (3/8) a 
patchy area of perivascular inflammation with 
macrophages was observed. Interestingly, in a few of 
the naive Smad3-/- animals the numbers of PAS 
-positive mucin producing cells were increased in the 
bronchial epithelium, no mucin producing cells could 
be detected in WT mice (Fig. 1b).  
The protein levels of the central Th2 cytokine IL-4 
was significantly increased in the BAL of naive 
Smad3-/- mice as compared to WT controls (Fig. 1a), 
furthermore the level of IL-5 protein was also 
increased although the absolute amount of IL-5 was 
small. The levels of IL-13 were barely above the 
detection limit. The levels of GATA-3 mRNA, a major 
Th2 associated transcription factor, were significantly 
higher in the lung tissue o f  n a i v e  S m a d 3 - / -  m i c e  
compared to that of WT mice (Fig. 1a). The mRNA 
expression of TGF-β was significantly increased in the 
lung of naive Smad3-/- mice compared to WT mice 
(Fig. 1a). The expression of IL-10 mRNA, another 
important regulatory cytokine, was significantly 
decreased in Smad3-/- mice. The expression of the 
proinflammatory cytokine IL-1β- and the chemokine 
MIP-1α (CCL3) mRNA was significantly upregulated 
in naive Smad3-/- mice lungs compared to WT mice. 
In contrast, no detectable levels of a major Th1 
cytokine IFN-γ mRNA were found in the lung tissue of 
Smad3-/- or WT mice (data not shown). 
 
Figure 1. Cytokines and morphology in the lungs of naive mice. The graphs in figure 1A depict the levels of proteins in BAL 
fluid (pg/ml) and the levels of mRNA (relative units, RU). Bars and errors represent mean ± SEM. *p<0.05, **p<0.01; n = 8 mice per 
group. The microscope image in figure 1B shows the mucin production in the lung of a WT mouse and a naive Smad3-/- mouse. 
Original magnification 200x . Int. J. Biol. Sci. 2007, 3 
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Effects of the Smad3 deletion on mouse airways in 
the asthma model 
In addition to the naive mice we also examined 
the effects of the Smad3 deletion in a mouse model of 
asthma. Airway hyperreactivity to inhaled 
metacholine, a hallmark of allergic asthma, was 
significantly increased in OVA sensitized Smad3-/- 
mice compared to PBS sensitized mice (Fig. 2a). In 
contrast, no significant differences between OVA and 
PBS sensitized mice were found in WT mice. Smad3-/- 
mice exhibited also clear symptoms, including some 
fatalities, of severe respiratory distress after airway 
metacholine exposure. In addition to increased 
bronchial hyperreactitivity, OVA sensitized Smad3-/- 
mice exhibited increased numbers of PAS -positive 
mucin producing cells compared to OVA sensitized 
WT mice (Fig. 2b). PBS treated Smad3-/- mice 
displayed also significantly increased numbers of 
PAS-positive cells in the bronchial epithelium 
c o m p a r e d  t o  W T  m i c e  ( F i g .  2 b ) .  H & E  s t a i n e d  l u n g  
sections from OVA sensitized Smad3-/- and WT mice 
showed peribronchiolar 
and perivascular 
inflammation consisting of 
lymphocytes and 
eosinophils, but no 
quantitative differences 
were observed (Fig. 2c). 
The infiltrate of Smad3-/- 
mice, but not WT mice, 
included occasionally 
neutrophils. Alveolar 
infiltrates of macrophages, 
eosinophils and 
neutrophils were 
frequently seen in saline 
treated Smad3-/- mice, but 
not in WT mice (Fig. 2c). 
 
Figure 2. AHR, mucin 
production and histology of 
the lungs in WT and 
Smad3-/- mice after OVA or 
saline exposure. Graph A 
shows the AHR response to 
metacholine (MCh). In graph 
B, the mucin production after 
OVA or saline exposure is 
shown. The results are shown 
as mean ± SEM. *p<0.05, 
**p<0.01, ***p<0.001; n = 11 
- 19 mice per group. The 
microscopic images in C show 
the hematoxylin and eosin 
(H&E)-stained lung sections of 
WT (right side) and Smad3-/- 
mice (left side) after saline 
(top) or OVA exposure 
(bottom). Original 
magnification of the main 
pictures: x 100 and the inserts x 
400. 
 Int. J. Biol. Sci. 2007, 3 
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We also examined the distribution of cell types in 
the BAL fluid of these mice. The number of eosinophils 
was significantly increased in the BAL fluid of 
OVA-sensitized WT and Smad3-/- mice compared to 
their PBS treated controls (Fig 3). There was also an 
increase in the numbers of eosinophils and neutrophils 
in PBS exposed Smad3-/- mice when compared to 
saline treated WT mice (Fig 3). Moreover the cell 
counts of PBS sensitized mice were higher in Smad3-/- 
mice compared to those of WT mice. 
OVA sensitizing caused the levels of IL-4 mRNA 
and IL-4 protein to rise significantly and to comparable 
levels in both Smad3-/- and WT mice (Fig. 4a). 
However, PBS treated Smad3-/- mice exhibited 
increased amounts of IL-4 mRNA and protein 
compared to PBS treated WT mice. The expression of 
mRNA for another major Th2 cytokine, IL-13, was 
significantly decreased in the lung of OVA sensitized 
Smad3-/- mice as compared to OVA sensitized WT 
mice (Fig. 4b). In line with this, no significant 
differences in the levels of IL-13 were found between 
OVA and PBS treated Smad3-/- mice (Fig. 4b). 
However the protein levels of IL-13 were significantly 
increased in the BAL fluid after OVA sensitization in 
WT mice compared to PBS treated controls. The lack of 
Smad3 tended to decrease the levels of IL-5 protein 
and mRNA in both PBS and OVA exposed mice (Fig. 
4c), it appears as if the levels of IL-5 protein in PBS 
exposed Smad3-/- mice would be lower than in the 
corresponding naive mice, the difference is however 
far from achieving significance. OVA evoked 
significant increases of IL-10 mRNA over the levels 
seen in PBS treated mice but the presence or absence of 
Smad3 did not have any effect on IL-10 mRNA. The 
levels of IL-10 mRNA after either PBS or OVA 
c h a l l e n g e s  w e r e ,  h o w e v e r ,  m u c h  h i g h e r  t h a n  t h o s e  
seen in naive mice (Figs. 1a and 4d). In contrast to the 
case with naive mice, no significant differences with 
respect to either the OVA vs PBS or the presence or 
absence of Smad3, could be observed for the 
expression of GATA-3 (data not shown).  
OVA-specific IgE levels (surrogate marker for 
Th2 type antibody response) were comparably 
increased both in Smad3-/- and WT mice sensitized 
with OVA (Fig. 5). In addition, the levels of 
OVA-specific IgG2a (surrogate marker for Th1 type 
antibody response) were increased after OVA 
sensitization in both mice groups. OVA-specific IgG2a 
levels were decreased in OVA sensitized Smad3-/- 
mice compared to their WT controls but the difference 
did not reach statistical significance (Fig. 5).  
 
Figure 3. Cell composition of the bronchoalveolar lavage fluid. The figure shows the proportion of different types of cells in WT 
and Smad3-/- mice after airway exposure to OVA or saline. * p < 0.05, ** p < 0.01; n = 11 - 14 mice per group. The cell 
concentrations (106 cells/liter BAL fluid ) were WT PBS 56,4 ±1,5; WT OVA 109,1±21.1; Smad3-/- PBS 149±2,6; Smad3-/- OVA 
151,0± 3,9. Int. J. Biol. Sci. 2007, 3 
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Figure 4. Cytokines in the lungs of mice in the asthma model. The graphs depict the levels protein in BAL fluid and the levels of 
mRNA. after airway exposure to OVA or saline. Bars and errors represent mean ± SEM. *p<0.05, **p<0.01, ***p<0.001; n = 13 - 19 
mice per PBS and OVA group. 
 
 
 
Figure 5. Mouse serum levels of OVA-specific IgE and IgG2a. The figure shows immunoglobulin levels in WT and Smad3-/- mice 
after airway exposure to OVA or saline. The data are shown as mean±SEM, *p<0.05, ***p<0.001; n = 13 - 20 mice per group. 
 
4.  DISCUSSION 
The role of Smad3 -signalling in the regulation of 
lung homeostasis and in the pathophysiology of 
respiratory diseases such as allergic asthma is poorly 
understood. It has been shown, however, that TGF-β is 
present in the airways and that the levels of certain 
TGF-β isoforms have been shown to be elevated in 
asthmatic airways. Another member of the TGF 
superfamily, activin A, has also been suggested to be Int. J. Biol. Sci. 2007, 3 
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involved in the pathogenesis of asthma [12, 13]. Since 
Smad3 is a critical mediator of TGF-β -signalling and 
activin A signalling, we utilized Smad3 deficient mice 
to explore the role of Smad3 -signalling in the 
regulation of lung functions both in the healthy 
situation as well as in the diseased state.  
Lung histology from naive Smad3-/- mice 
revealed that the lack of TGF-β −signalling caused a 
marginal infiltrate of lymphocytes and occasionally 
modest increases in mucin production in the bronchial 
epithelium. These changes were accompanied by 
significant increases in the expression of Th2 cytokine 
IL-4 and GATA-3, an important transcription factor 
regulating IL-4 expression. Similarly IL-5 was also 
significantly increased although the absolute level 
remained low. The levels of IL-13 were almost 
nonexistent. It has been shown that GATA-3 
expression is suppressed by TGF-β [23]. Thus, the 
increase of GATA-3 and IL-4 could be viewed to result 
from the release from TGF-β suppression of GATA-3. 
In addition to the increase in Th2 cytokines, we found 
a significant elevation in the expression of 
proinflammatory cytokines and chemokines (IL-1β 
and MIP-1α, respectively), the latter being indicative of 
macrophage activation. In line with this finding, a 
tendency towards activation of macrophages with 
regard to matrix metalloproteinases has been observed 
by Bonniaud et al. in Smad3 knockout mice [24]. The 
expression levels of a regulatory cytokine, IL-10, were 
completely abolished in naive Smad3 deficient mice 
compared to WT mice. The baseline levels of IL-10 in 
the lungs of WT mice are, however, quite low and it is 
therefore unclear whether this additional reduction 
could lead to the increased expression of 
proinflammatory cytokines and IL-4 seen. The reason 
for the decrease of IL-10 as well as the reasons for the 
low levels of IL-5 and IL-13 could be that the presence 
of Smad3 is required for GATA3 regulation [25], this is 
discussed in association with the asthma model. 
Our results suggest that Smad3 signalling is 
important in the suppression of the proinflammatory 
as well as the IL-4 response in the airways in the 
healthy condition, it should be noted that the 
suppressed features mentioned are also associated 
with asthma. 
When studying the lungs of mice exposed to 
allergen in the asthma model we found that there was 
a pronounced increase in the amount of mucin in both 
PBS and OVA treated Smad3-/- mice compared to WT 
mice. Our results also revealed that airway 
hyperreactivity to inhaled metacholine, a classical 
hallmark of allergic asthma, was significantly 
increased in OVA sensitized Smad3-/- mice. In 
contrast, no significant differences between OVA and 
P B S  s e n s i t i z e d  m i c e  w e r e  f o u n d  i n  W T  m i c e .  T h e s e  
results probably underestimate the actual degree of 
AHR since C57BL/6 mice (strain used in the present 
study) are more resistant to bronchoconstrictors than 
other mouse strains, and differences between mice 
might be difficult to observe using whole body 
plethysmography [24]. Indeed, we were able to 
observe signs of respiratory distress in Smad3-/- mice 
after allergen exposure but no symptoms were visible 
in WT mice. Taken together, we found that the lack of 
Smad3-/- signalling led to an exaggerated asthmatic 
phenotype in allergic asthma model. The exaggerated 
asthmatic phenotype seen in this work resembles that 
seen in the work of Nakao et al [18] where expression 
of the inhibitory Smad7 was used to disturb signalling.   
Naive Smad3 deficient mice demonstrated 
elevated levels of IL-4 protein in their lungs. In line 
with this, the levels of IL-4 mRNA and protein in the 
airways of PBS treated Smad3-/- mice were 
significantly increased compared to PBS treated WT 
mice. However, the IL-4 levels were equivalently 
increased in OVA sensitized Smad3-/- and WT mice. 
These results suggest that cytokines belonging to the 
TGF superfamily play an important role in the 
regulation of IL-4 production in the normal state but 
their significance is less critical during inflammation 
induced in this case by immunization with OVA 
allergen and/or adjuvant. In contrast to IL-4 
expression, the levels of IL-13 (another important Th2 
type cytokine) were significantly decreased in OVA 
sensitized lungs of Smad3-/- mice compared to WT 
mice. It has been previously reported that GATA-3 
interacts extensively and apparently directly with 
Smad3 to regulate GATA target genes, including IL-10 
and IL-5, through GATA3 binding sites in the 
promoter regions [25]. Thus the low level of increase of 
IL-5 and the decrease of IL-10 in naive Smad3-/- mice 
could be caused by an inhibition of GATA-3 function 
by the lack of Smad3. IL-13 is regulated through a 
GATA-3 binding promoter region [26], but there are no 
earlier reports that its expression would be dependent 
on Smad3 [25]. Our findings, interestingly, suggest a 
critical dependence of GATA-3 for Smad3 in 
regulating IL-13 expression. In contrast, no GATA 
binding exists in the IL-4 promoter and GATA-3 
regulates IL-4 production through distal regulatory 
elements [26-28]. In the asthma model, in contrast to 
naive mice, there were no significant differences in the 
amounts of GATA-3 mRNA levels between Smad3-/- 
and WT. Furthermore, IL-10 levels in the asthma 
model were much higher than in the naive state and 
they did not reveal any significant differences between 
Smad3-/- and WT mice mice, suggesting that there is a 
difference in the regulation of GATA3 and IL-10 
cytokines in the naive state and the inflamed state. In 
the case of IL-10 it appears that in PBS exposed lungs 
other regulatory mechanisms override the lack of 
GATA3 and increase IL-10 mRNA levels substantially 
as compared to naive mice. Taken together, we think 
that the unexpectedly low levels or decreases of IL-5, 
IL-10, and IL-13 in various contexts can best be 
explained by a need for interactions between GATA3 
and Smad3. However, depending on the situation, 
there are obviously other regulatory mechanisms that 
strongly affect the expression of these cytokines. 
Further studies are needed to clarify the molecular 
mechanisms for GATA3 and Smad3 effects on cytokine 
expression. Int. J. Biol. Sci. 2007, 3 
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Increased amounts of IL-13 have been previously 
associated with increased airway hyperreactivity and 
mucus overproduction. It is interesting that in the 
present study Smad3 deficient mice with diminished 
IL-13 production clearly exhibited increased airway 
hyperreactivity and substantially increased mucus 
production. This result is in agreement with the 
finding of Perkins et al [29] demonstrating a role for 
IL-4 in promoting all the Th2 tissue responses 
independent of IL-13. 
Our results are in many respects contradictory to 
those described by Le et al [30].They showed that a 
Smad3 deletion led to a decrease in mucin production 
and eosinophilia whereas no changes was seen with 
the AHR. The probable reason for this discrepancy is 
that in the work of Le et al a different Smad3 deletion 
was used, i.e that described by Zhu et al in 1998 [31] 
which has exons 2 deleted on both alleles. In contrast 
we have used a Smad3 deletion where exons 8 on both 
alleles were deleted [19]. It is well known that these 
different Smad3 deletions often give contradictory 
results. Perhaps the most interesting feature of the 
Smad3 (exon 2) deletion is a major increase in the 
incidence of colonic cancer. No increases in colonic 
cancer has been reported from the Smad3 (exon 8) 
deletions. As far as we know the reason for these 
discrepancies have not been fully determined, Yang et 
al 1999 [19] has discussed this topic to some extent in 
his article and propose a possible explanation i.e. that 
some part of the mutant transcript (exons 4-9) could 
actually be translated in the Smad3 (exon 2) deletion. 
In contrast there is evidence showing that no part of 
the mutant transcript in the Smad3 (exon 8) deletion is 
translated. In addition there are differences in the 
genetic background of the mice but according to Yang 
et al this is not likely to explain the discrepancies 
between the different Smad3 deletions. Thus, it is 
possible that the explanation for the differences 
between our results and those of Le et al is that in the 
latter case a part of Smad3 is translated. If we now 
consider other models where TGF-β or its receptor has 
been manipulated the results are in many ways similar 
to the data concerning the inflammatory state 
presented here i.e. eosinophilia and AHR is increased 
and mucin production is increased when TGF β1 levels 
or effect are decreased [11, 18]. Thus we think that our 
results are much more likely to reflect a generalizable 
role for Smad3 signalling in asthma.  
TGF-β is not entirely dependent on Smad 
dependent pathways for its signalling [32, 33] and a 
total lack of TGF-β will cause a much more severe 
phenotype than that seen in the Smad3-/- mice [2]. 
This study showed that a lack of Smad3 in naive mice 
caused an increase in the central Th2 transcription 
factor GATA-3 and changes in IL-4 and 
proinflammatory cytokine levels. Interestingly the lack 
of Smad3 and presumably TGF-β signalling led to an 
exaggerated asthmatic phenotype in an asthma model, 
in line with earlier findings. However, this 
exaggerated asthmatic phenotype was not 
accompanied by any increase in IL-4 or other Th2 
cytokines, in contrast to earlier findings with other 
forms of inhibition of TGF-β [11, 18] in asthma models. 
This indicates that in the inflammatory state, TGF-β or 
related cytokines function as a counterbalance to IL-4 
effects rather than as a regulator of its expression. 
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